Search research articles
Contact Us
Filters
Showing results (1-10 of 39) with videos related to
Page
of 4
Sort By:
Advances in Experimental Medicine and Biology
|
September 10, 2013
TP53 aberrations in chronic lymphocytic leukemia
Martin Trbusek, Jitka Malcikova
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 27, 2002
5-Methylcytosine as a marker for the monitoring of DNA methylation
Jan Havlis, Martin Trbusek
Cancer Treatment Reviews
|
June 28, 2020
ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias
Miroslav Boudny, Martin Trbusek
Leukemia Research
|
March 8, 2011
Selection of new TP53 mutations by therapy in chronic lymphocytic leukemia
Martin Trbusek, Jitka Malcikova, Jiri Mayer
Methods in Molecular Biology (Clifton, N.J.)
|
October 24, 2018
Detection and Functional Analysis of TP53 Mutations in CLL
Sarka Pavlova, Jana Smardova, Nikola Tom, et al.
Leukemia Research
|
January 12, 2020
PRIMA-1<sup>MET</sup> cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells
Zuzana Jaskova, Sarka Pavlova, Jitka Malcikova, et al.
Leukemia & Lymphoma
|
July 2, 2013
The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells
Veronika Navrkalova, Ludmila Sebejova, Jana Zemanova, et al.
Biological Chemistry
|
February 5, 2010
Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation
Jitka Malcikova, Boris Tichy, Jiri Damborsky, et al.
Leukemia & Lymphoma
|
April 2, 2015
NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines
Jan Verner, Martin Trbusek, Jana Chovancova, et al.
The Journal of Molecular Diagnostics : JMD
|
March 16, 2010
High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival
Jana Kotaskova, Boris Tichy, Martin Trbusek, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 39) with videos related to
Sort By:
Page
of 4
Advances in Experimental Medicine and Biology
|
September 10, 2013
TP53 aberrations in chronic lymphocytic leukemia
Martin Trbusek, Jitka Malcikova
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 27, 2002
5-Methylcytosine as a marker for the monitoring of DNA methylation
Jan Havlis, Martin Trbusek
Cancer Treatment Reviews
|
June 28, 2020
ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias
Miroslav Boudny, Martin Trbusek
Leukemia Research
|
March 8, 2011
Selection of new TP53 mutations by therapy in chronic lymphocytic leukemia
Martin Trbusek, Jitka Malcikova, Jiri Mayer
Methods in Molecular Biology (Clifton, N.J.)
|
October 24, 2018
Detection and Functional Analysis of TP53 Mutations in CLL
Sarka Pavlova, Jana Smardova, Nikola Tom, et al.
Leukemia Research
|
January 12, 2020
PRIMA-1<sup>MET</sup> cytotoxic effect correlates with p53 protein reduction in TP53-mutated chronic lymphocytic leukemia cells
Zuzana Jaskova, Sarka Pavlova, Jitka Malcikova, et al.
Leukemia & Lymphoma
|
July 2, 2013
The p53 pathway induction is not primarily dependent on Ataxia Telangiectasia Mutated (ATM) gene activity after fludarabine treatment in chronic lymphocytic leukemia cells
Veronika Navrkalova, Ludmila Sebejova, Jana Zemanova, et al.
Biological Chemistry
|
February 5, 2010
Analysis of the DNA-binding activity of p53 mutants using functional protein microarrays and its relationship to transcriptional activation
Jitka Malcikova, Boris Tichy, Jiri Damborsky, et al.
Leukemia & Lymphoma
|
April 2, 2015
NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines
Jan Verner, Martin Trbusek, Jana Chovancova, et al.
The Journal of Molecular Diagnostics : JMD
|
March 16, 2010
High expression of lymphocyte-activation gene 3 (LAG3) in chronic lymphocytic leukemia cells is associated with unmutated immunoglobulin variable heavy chain region (IGHV) gene and reduced treatment-free survival
Jana Kotaskova, Boris Tichy, Martin Trbusek, et al.
Page
of 4